Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices

Trial N/A Active, not recruiting March 17, 2026

Intracranial Recordings to Characterize Action Regulation Mechanisms

Trial N/A Enrolling by invitation March 16, 2026

Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core

Trial N/A Enrolling by invitation March 16, 2026

Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Trial N/A Completed March 15, 2026

UB-312 in Patients With Synucleinopathies

Trial Phase 1 Completed March 15, 2026

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Trial N/A Recruiting March 15, 2026

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Trial Phase 1 Recruiting March 15, 2026

Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.

Trial Phase 2 Completed March 15, 2026

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Trial Phase 2 Completed March 15, 2026

Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

Trial N/A Recruiting March 15, 2026

Exercise to Improve Sleep in Parkinson's Disease

Trial N/A Recruiting March 12, 2026

Allopregnanolone as a Regenerative Treatment for Parkinson's Disease

Trial Phase 1 Completed March 12, 2026

Parkinson's Disease Biomarker Study

Trial N/A Completed March 12, 2026

Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease

Trial Phase 2 Completed March 12, 2026

Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

Trial Phase 2 Not yet recruiting March 12, 2026

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Trial Phase 4 Terminated March 12, 2026

Montelukast in Parkinson Disease

Trial Phase 2 Recruiting March 12, 2026

Aerobic Exercise in Parkinson's Disease

Trial N/A Completed March 11, 2026

Tackling Anxiety-related Freezing of Gait in People With Parkinson's Disease

Trial N/A Completed March 11, 2026

Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism

Trial Phase 2 Completed March 11, 2026